In resource-limited settings, genomic assays for hormone receptor-positive, HER2-negative breast cancer aren't always accessible. Yet treatment decisions still need to be made -- often quickly and ...

Marija Balic, MD, discusses how circulating tumor DNA assays for molecular residual disease detection have evolved in recent ...

Spatial biology has emerged as a highly valuable field of study, examining the relationships between biological cells and molecules in their native spatial orientation, which can occur in both ...

Multicancer early detection (MCED) assays use circulating tumor DNA, methylation patterns, RNA, and protein biomarkers to detect multiple cancer types early, potentially revolutionizing cancer ...

The Stagljar Lab is a global leader in proteomics and chemical genomics, specializing in unraveling protein-protein interactions of human membrane proteins. Pivotal in cancer and rare genetic diseases ...

The shift towards utilizing complex organ-like structures developed from stem cells or tissue samples is becoming essential; these organoid models are leading the way to next-generation, animal-free ...

Researchers studied synthetic lethality pathway using Promega NanoBRET(R) TE technology -- Study is the first to characterize uncompetitive binding directly in live cells, illuminating a mechanistic ...

A pair of well-known marijuana compounds work in tandem to target ovarian cancer cells In A Nutshell CBD and THC killed ...